Slfn12L inhibitors are a class of chemical compounds designed to selectively target and inhibit the function of Schlafen family member 12-like (Slfn12L), a protein within the Schlafen protein family. The Schlafen proteins are involved in the regulation of cellular processes, including growth, differentiation, and immune responses. Slfn12L, in particular, has a unique role within this family, influencing gene expression and cellular homeostasis. Inhibitors of Slfn12L work by binding to specific regions of the protein, preventing its normal activity within the cell. This inhibition can disrupt key protein interactions, post-translational modifications, or other biochemical pathways regulated by Slfn12L. The ability of these compounds to modulate Slfn12L activity offers researchers valuable tools for studying the cellular processes governed by this protein.
The structural biology of Slfn12L provides insight into how inhibitors are designed to interact with it. Understanding its binding sites, active domains, and the overall conformation of the protein allows for the rational design of inhibitors with high specificity and affinity. These inhibitors can act by blocking the protein's catalytic activity, altering its folding, or preventing its interaction with essential co-factors or other regulatory proteins. The activity of Slfn12L inhibitors is often characterized using biochemical and biophysical techniques, such as enzyme kinetics, protein binding assays, and structural analysis. Through these methods, researchers can evaluate the effectiveness of the inhibitors in modulating Slfn12L's function and explore their broader impact on cellular pathways that depend on the regulation of this protein. The development and study of Slfn12L inhibitors thus contribute to a deeper understanding of the biological functions of the Schlafen family.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K which is involved in many signaling pathways; can indirectly influence Slfn12L-associated processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that affects various cellular processes and pathways that may interact with Slfn12L. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, affecting stress and inflammatory pathways that might indirectly modulate Slfn12L functionality. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, a kinase involved in multiple cellular responses, potentially impacting Slfn12L interactions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor which may influence ERK pathways potentially related to Slfn12L. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator in cell growth and proliferation pathways, potentially influencing Slfn12L. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Can inhibit calcineurin, influencing NFAT signaling which might indirectly impact pathways linked to Slfn12L. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
Pan-caspase inhibitor that affects apoptosis processes, potentially having indirect influence on Slfn12L. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore which alters intracellular calcium levels, potentially impacting pathways related to Slfn12L. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor that affects various signaling pathways, potentially indirectly modulating Slfn12L. | ||||||